AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Clinical Trial Of Monoclonal Antibody Offered At Florida Site.(Brief Article)
2001 DEC 26 - (NewsRx.com & NewsRx.net) -- M.D. Anderson Cancer Center, Orlando, Florida, is one of four sites nationwide to conduct a clinical trial using Erbitux (formerly IMC-C225), an investigational monoclonal antibody, for previously untreated stage IV non-small cell lung cancer.
The disease, which strikes more than 164,000 Americans annually, is often fatal and has a very low cure rate. The drug was developed in part by Dr. John Mendelsohn, president of the University of Texas M.D. Anderson Cancer Center in Houston, Texas. It is being clinically developed by ImClone Systems, Incorporated.
Lung cancer is the leading cause of cancer-related deaths in both men and women. More people die from the disease than breast, colon and prostate cancer combined, and it kills nearly twice as many women each year as does breast cancer.
Non-small cell lung cancer, named for how the cells appear under a microscope, is the most common form of lung cancer. Most lung cancers are detected only when they cause symptoms, by which time the cancer is usually too extensive to be cured. Only 14% of those diagnosed with lung cancer live five years.
"Because of the incurable nature of stage IV non-small cell lung cancer, it's very encouraging to evaluate a novel therapy that may lead to better treatments for such a devastating disease," said Dr. Jennifer Tseng, principal investigator for the Erbitux trial at M.D. Anderson - Orlando.
Erbitux ...
- M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R)...
- Press release article from: PR Newswire October 26, 2007 700+ words
...University of Texas M. D. Anderson Cancer Center in Houston, Texas...in early-stage operable lung cancer. Patients in the study will...alternatives for early stage lung cancer patients," said Jack Roth...traditional surgery for early stage lung cancer patients and a ...
- Accuray (Sunnyvale, California), which focuses on radiosurgery, said that the...
- Newspaper article from: Diagnostics & Imaging Week November 1, 2007 700+ words
...University of Texas M. D. Anderson Cancer Center (Houston) to launch...in early-stage operable lung cancer. Patients in the study will...alternatives for early stage lung cancer patients," said Jack Roth...excellent outcomes treating lung cancer with CyberKnife ...
- Rosetta Genomics (Rehovot, Israel) is collaborating with the University of...
- Newspaper article from: Diagnostics & Imaging Week June 12, 2008 700+ words
...University of Texas M. D. Anderson Cancer Center (Houston) and the...of disease recurrence in lung cancer patients who have undergone...resection. Current treatment for lung cancer includes surgical resection...this important project in lung cancer. We believe that the ...
- Diet, activity may influence lung cancer risk.(Pulmonary Medicine)
- Magazine article from: Internal Medicine News Wachter, Kerri March 1, 2008 700+ words
...risk of developing lung cancer in non-Hispanic...of Texas M.D. Anderson Cancer Center, Houston...increased risk of lung cancer among current smokers...white patients with lung cancer from the M.D. Anderson Cancer Center and matched...
- Studies reveal differences in lung cancer.
- Newspaper article from: The Dallas Morning News (via Knight-Ridder/Tribune News Service) March 1, 2005 700+ words
...the next level of treatment for lung cancer," said Dr. Roy Herbst, a lung cancer specialist at M.D. Anderson Cancer Center in Houston. "This is very...East Asian origin _ in a subtype of lung cancer known as adenocarcinoma _ and in...
- AEterna announces the commencement of patient enrollment for the NIH -...
- Press release article from: PR Newswire May 17, 2000 700+ words
...small-cell lung cancer tumors, the most common type of lung cancer. The University of Texas M. D. Anderson Cancer Center is the...radiotherapy, can help lung cancer patients live...Texas M. D. Anderson Cancer Center. ``Patients...
- Hycamtin(TM) Achieves Promising Results in Patients With Non-Small Cell Lung...
- Press release article from: PR Newswire May 19, 1997 700+ words
...non-small cell lung cancer is very difficult...Texas, M.D. Anderson Cancer Center in Houston, Texas. Lung Cancer: A Widespread...reported by M.D. Anderson Cancer Center in the...non-small cell lung cancer who had not been...
- Why some non-smokers have lung cancer risk.
- News wire article from: UPI NewsTrack June 27, 2008 700+ words
...fold increased risk of lung cancer. Researchers at The...University of Texas M. D. Anderson Cancer Center in Houston say...as likely to develop lung cancer. The study found participants...risk of developing lung cancer. "Our findings demonstrate...
- New Data Suggest Introgen's FUS1 Therapy May Play Role in Preventing Onset of...
- Press release article from: PR Newswire June 24, 2004 700+ words
...the early onset of lung cancer. Introgen's collaborators...University of Texas M. D. Anderson Cancer Center and The UT Southwestern...1 clinical trial in lung cancer being conducted by...researchers from M. D. Anderson Cancer Center, UT Southwestern...
- Lung Cancer, 3rd Edition Available Now.
- Press release article from: Business Wire February 1, 2008 700+ words
...first edition of Lung Cancer was published...Texas M.D. Anderson Cancer Center, Department...Texas M.D. Anderson Cancer Center, Houston...Texas M.D. Anderson Cancer Center, Houston...Cessation - Lung Cancer Susceptibility...
Source: HighBeam Research, Clinical Trial Of Monoclonal Antibody Offered At Florida Site.(Brief...